Related Experiment Video

Updated: Aug 16, 2026

Seven Steps to Stellate Cells
06:40

Seven Steps to Stellate Cells

Published on: May 10, 2011

Stevens-Johnson syndrome in children

C M Ginsburg

    Pediatric Infectious Disease
    |May 1, 1982
    PubMed

    Insights

    Stevens-Johnson syndrome (SJS) in children is often preceded by infections or medications. Adrenocorticosteroid treatment for SJS in pediatric patients was associated with increased infection and complication rates, suggesting it should be avoided.

    Area of Science:

    • Pediatric Medicine
    • Dermatology
    • Infectious Diseases

    Background:

    • Stevens-Johnson syndrome (SJS) is a severe mucocutaneous reaction.
    • Pediatric SJS cases often follow infections or medication exposure.
    • The efficacy and safety of SJS treatments in children require further investigation.

    Purpose of the Study:

    • To evaluate the impact of adrenocorticosteroid treatment on SJS outcomes in pediatric patients.
    • To compare complication rates between steroid-treated and non-steroid-treated SJS cases in children.

    Main Methods:

    • Retrospective analysis of 51 pediatric SJS cases over 22 years.
    • Comparison of clinical characteristics and outcomes between patients treated with and without adrenocorticosteroids.
    • Analysis of antecedent factors, including infections and medications.

    Main Results:

    • 67% of pediatric SJS patients received prescription medication prior to onset.
    • Adrenocorticosteroid treatment was administered to 37% of hospitalized patients.
    • Steroid-treated patients experienced significantly higher rates of infection and overall complications compared to non-steroid-treated patients.

    Conclusions:

    • Adrenocorticosteroid therapy in pediatric Stevens-Johnson syndrome is associated with increased adverse events.
    • Symptomatic treatment appears to be a safer approach for managing SJS in infants and children.
    • Avoidance of adrenocorticosteroids is recommended for pediatric SJS management.

    More Related Videos

    Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis10:27

    Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

    Published on: December 15, 2011

    Related Concept Videos

    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

    Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
    Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

    Pharmacokinetics in Pediatric Patients: Drug Metabolism

    In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
    Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

    Pharmacokinetics in Pediatric Patients: Drug Excretion

    In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
    Hypersensitivity Reactions: Cytolytic Reactions01:01

    Hypersensitivity Reactions: Cytolytic Reactions

    Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
    Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

    Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

    Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
    Hypersensitivity Reactions: Immune-Complex Reactions01:19

    Hypersensitivity Reactions: Immune-Complex Reactions

    Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...